Bill Information - History

House Bill 2527; Regular Session 2021-2022

[History]

Sponsors:

QUINN, GUENST, POLINCHOCK, HILL-EVANS, CIRESI, STRUZZI, N. NELSON, SAPPEY, ROWE, GILLEN, ZIMMERMAN, WEBSTER, C. WILLIAMS and FRANKEL

Printer's No.(PN):

3150*, 3004

Short Title:

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.

Actions:

	PN 3004	Referred to JUDICIARY, April 20, 2022
	PN 3150	Reported as amended, May 24, 2022
		First consideration, May 24, 2022
		Laid on the table, May 24, 2022
		Removed from table, June 14, 2022
		Second consideration, June 15, 2022
		Re-committed to APPROPRIATIONS, June 15, 2022
		Re-reported as committed, June 20, 2022
		Third consideration and final passage, June 20, 2022 (200-0)
		(Remarks see House Journal Page 666-667), Oct. 20, 2022
		In the Senate
		Referred to JUDICIARY, June 21, 2022
		Reported as committed, Sept. 20, 2022
		First consideration, Sept. 20, 2022
		Second consideration, Oct. 18, 2022
		Re-referred to APPROPRIATIONS, Oct. 18, 2022
		Re-reported as committed, Oct. 24, 2022
		Third consideration and final passage, Oct. 24, 2022 (48-0)
		(Remarks see Senate Journal Page 1084-1087), Oct. 24, 2022
		Signed in House, Oct. 25, 2022
		Signed in Senate, Oct. 26, 2022
		Presented to the Governor, Oct. 26, 2022
		Approved by the Governor, Nov. 3, 2022
		Act No. 135 of 2022, Nov. 3, 2022

* denotes current Printer's Number

How to Read a Bill About PDF Documents